Rhythm Pharmaceuticals Ratios and Metrics

Market cap in millions MXN. Fiscal year is January - December.

Millions MXN. Fiscal year is Jan - Dec.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Nov '25 Nov 17, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020
Market Capitalization	118,338	71,688	45,928	32,007	10,285	26,151
Market Cap Growth	64.83%	56.09%	43.49%	211.21%	-60.67%	37.47%
Enterprise Value	115,647	70,779	40,893	25,264	3,608	22,199
Last Close Price	1866.76	958.00	553.07	550.00	185.04	610.00
PS Ratio	37.01	26.44	35.09	69.42	159.06	-
PB Ratio	21.82	20.91	16.00	6.21	1.77	7.89
P/TBV Ratio	45.03	221.17	16.69	6.40	1.80	7.89
EV/Sales Ratio	38.48	26.10	31.24	54.79	55.81	-
Debt / Equity Ratio	0.38	0.69	0.63	0.29	0.01	0.02
Asset Turnover	0.40	0.36	0.22	0.07	0.01	-
Inventory Turnover	1.03	0.98	1.61	1.41	-	-
Quick Ratio	4.31	2.94	5.27	8.53	6.81	9.60
Current Ratio	4.75	3.24	5.58	8.90	7.10	10.10
Return on Equity (ROE)	-85.79%	-155.91%	-85.10%	-66.05%	-30.89%	-59.88%
Return on Assets (ROA)	-26.74%	-45.77%	-32.22%	-31.45%	-41.15%	-34.45%
Return on Capital Employed (ROCE)	-46.30%	-95.90%	-66.40%	-52.30%	-59.40%	-80.80%
Earnings Yield	-3.06%	-7.58%	-6.80%	-11.04%	-13.88%	-10.20%
FCF Yield	-	-3.31%	-5.01%	-10.59%	-29.19%	-9.30%
Buyback Yield / Dilution	-5.39%	-5.76%	-10.65%	-5.08%	-12.40%	-21.15%

Source: S&P Global Market Intelligence. Standard template. Financial Sources.